Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3039% below fair value
$3.13−0.02 (-0.79%)
Close on Nov 13, 2026Market cap $617.33MP/E –Yield –
Wave Life Sciences operating margin
Operating margin is operating income as a percentage of revenue.
Wave Life Sciences's operating margin for the twelve months ending Sep 30, 2026 was -320.9%. For fiscal 2025 it was -504.1%, against -101.9% the year before. The highest annual figure on record is -60.0% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -504.1% | −402.2 |
| FY2024 | Dec 31, 2024 | -101.9% | −41.9 |
| FY2023 | Dec 31, 2023 | -60.0% | +4399.3 |
| FY2022 | Dec 31, 2022 | -4459.3% | −4149.2 |
| FY2021 | Dec 31, 2021 | -310.1% | +453.9 |
| FY2020 | Dec 31, 2020 | -763.9% | +539.4 |
| FY2019 | Dec 31, 2019 | -1303.4% | −196.6 |
| FY2018 | Dec 31, 2018 | -1106.7% | +1523.4 |
| FY2017 | Dec 31, 2017 | -2630.1% | +2472.4 |
| FY2016 | Dec 31, 2016 | -5102.6% | +7593.5 |
| FY2015 | Dec 31, 2015 | -12696.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -502.0% | +238.8 |
| Q2 FY2026 | Jun 30, 2026 | -3248.3% | −2641.8 |
| Q1 FY2026 | Mar 31, 2026 | -81.8% | +461.0 |
| Q4 FY2025 | Dec 31, 2025 | -327.4% | −149.7 |
| Q3 FY2025 | Sep 30, 2025 | -740.7% | −465.9 |
| Q2 FY2025 | Jun 30, 2025 | -606.5% | −542.2 |
| Q1 FY2025 | Mar 31, 2025 | -542.8% | −551.9 |
| Q2 FY2024 | Jun 30, 2024 | -177.7% | −71.5 |
| Q1 FY2024 | Mar 31, 2024 | -274.8% | −40.6 |
| Q4 FY2023 | Dec 31, 2023 | -64.3% | +3451.7 |
| Q3 FY2023 | Sep 30, 2023 | 9.0% | +13657.8 |
| Q2 FY2023 | Jun 30, 2023 | -106.2% | +11137.5 |
| Q1 FY2023 | Mar 31, 2023 | -234.2% | +1942.6 |
| Q4 FY2022 | Dec 31, 2022 | -3516.0% | −1470.1 |
| Q3 FY2022 | Sep 30, 2022 | -13648.8% | −13627.9 |
| Q2 FY2022 | Jun 30, 2022 | -11243.7% | −9809.0 |
| Q1 FY2022 | Mar 31, 2022 | -2176.8% | −1855.7 |
| Q4 FY2021 | Dec 31, 2021 | -2045.9% | −1048.4 |
| Q3 FY2021 | Sep 30, 2021 | -20.9% | +1256.2 |
| Q2 FY2021 | Jun 30, 2021 | -1434.7% | −233.3 |
| Q4 FY2020 | Dec 31, 2020 | -321.1% | +2201.1 |
| Q3 FY2020 | Sep 30, 2020 | -997.5% | +852.2 |
| Q2 FY2020 | Jun 30, 2020 | -1277.0% | −679.0 |
| Q1 FY2020 | Mar 31, 2020 | -1201.5% | +384.4 |
| Q4 FY2019 | Dec 31, 2019 | -2522.2% | −1170.2 |
| Q3 FY2019 | Sep 30, 2019 | -1849.7% | −998.8 |
| Q2 FY2019 | Jun 30, 2019 | -598.0% | +151.6 |
| Q1 FY2019 | Mar 31, 2019 | -1585.9% | +930.0 |
| Q4 FY2018 | Dec 31, 2018 | -1352.0% | +1485.7 |
| Q3 FY2018 | Sep 30, 2018 | -850.9% | +1153.1 |
| Q2 FY2018 | Jun 30, 2018 | -749.6% | +1499.5 |
| Q1 FY2018 | Mar 31, 2018 | -2515.8% | +2760.2 |
| Q4 FY2017 | Dec 31, 2017 | -2837.7% | −100.4 |
| Q3 FY2017 | Sep 30, 2017 | -2004.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -2249.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -5276.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -2737.3% | – |
See a number that looks wrong?